The human body produces and removes 1011 platelets daily to maintain a normal steady-state platelet count, and the level of production can be greatly increased under conditions of platelet destruction. We provided the first evidence that survival of platelets is intimately tied to surface glycans and have shown that platelets with impaired Siaa2-3Galb1-4GlcNAc (LacNAc) structures are removed in the liver by Kupffer cells and hepatocytes. Here, we continue to investigative this path and will dissect how targeting to hepatocytes or Kupffer cells is regulated.
Aim 1 proposes to define the differential roles of hepatic and macrophage galactose- binding receptors in terminating platelet circulation and will dissect the contribution of O- and N-linked glycan recognition by each of these receptors. We will survey platelet glycoproteins from mice deficient for the hepatic asialoglycoprotein receptor2 (Asgr2), the macrophage galactose lectin (MGL), or both to define the glycan- bearing platelet ligands for the Asgr and MGL, as these platelets carry increased levels of desialylated proteins because of diminished clearance. Further, use of mice deficient in sialyltransferase 3 (ST3) Gal-I or Gal-IV that normally sialylate N-linked or O-linked glycans will decipher the relative roles o desialylated O- and N-linked glycans as ligands for these galactose receptors. Characterization of the desialylated targets will reveal which are normally modified in circulating blood. This data will be compared to those found in stored blood. Lastly, we will establish if desialylation of O- o N-linked glycans promotes GPIba release by TACE. Our work further suggests the existence of novel and continuous crosstalk between platelets, liver cells and bone marrow. Liver regeneration depends on the delivery of factors to hepatocytes by platelets and on the expression of the Asgr1/2.
Aim 2 will address the role of O- and N-linked asialoglycans in platelet ingestion by hepatocytes and determine the functional consequences focusing on how they influence hepatocyte homeostasis as well as remodeling following liver injury. In addition we will begin to investigate how impaired glycan-mediated platelet uptake by hepatocytes leads to bone marrow abnormalities. We will carefully determine the proportion of hematopoietic stem cells (HSCs) and osteoblastic niche cells and stromal cells in Asgr2-/-, ST3GalIV-/- and WT bone marrows (BMs). The hypothesis that systemic signals altered in the absence of Asgr1/2 regulate BM homeostasis will be solidified, and we will begin to identify these systemic factors.

Public Health Relevance

The only current solution to thrombocytopenia is platelet transfusion and procedures to obtain and store platelets lead to damage that targets many for removal. The understanding of the underlying mechanisms of platelet removal is crucial for development of novel concepts to improve platelet transfusion as treatment of thrombocytopenia.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Project (R01)
Project #
5R01HL089224-07
Application #
8643819
Study Section
Hemostasis and Thrombosis Study Section (HT)
Program Officer
Sarkar, Rita
Project Start
2007-09-05
Project End
2017-03-31
Budget Start
2014-04-01
Budget End
2015-03-31
Support Year
7
Fiscal Year
2014
Total Cost
$410,473
Indirect Cost
$165,473
Name
Brigham and Women's Hospital
Department
Type
DUNS #
030811269
City
Boston
State
MA
Country
United States
Zip Code
02115
Lee-Sundlov, Melissa M; Ashline, David J; Hanneman, Andrew J et al. (2016) Circulating blood and platelets supply glycosyltransferases that enable extrinsic extracellular glycosylation. Glycobiology :
Li, Renhao; Hoffmeister, Karin M; Falet, Hervé (2016) Glycans and the platelet life cycle. Platelets 27:505-11
Hoffmeister, Karin M; Falet, Hervé (2016) Platelet clearance by the hepatic Ashwell-Morrell receptor: mechanisms and biological significance. Thromb Res 141 Suppl 2:S68-72
Begonja, Antonija Jurak; Pluthero, Fred G; Suphamungmee, Worawit et al. (2015) FlnA binding to PACSIN2 F-BAR domain regulates membrane tubulation in megakaryocytes and platelets. Blood 126:80-8
Li, June; van der Wal, Dianne E; Zhu, Guangheng et al. (2015) Desialylation is a mechanism of Fc-independent platelet clearance and a therapeutic target in immune thrombocytopenia. Nat Commun 6:7737
Bender, Markus; Giannini, Silvia; Grozovsky, Renata et al. (2015) Dynamin 2-dependent endocytosis is required for normal megakaryocyte development in mice. Blood 125:1014-24
Grozovsky, Renata; Giannini, Silvia; Falet, Hervé et al. (2015) Regulating billions of blood platelets: glycans and beyond. Blood 126:1877-84
Grozovsky, Renata; Begonja, Antonija Jurak; Liu, Kaifeng et al. (2015) The Ashwell-Morell receptor regulates hepatic thrombopoietin production via JAK2-STAT3 signaling. Nat Med 21:47-54
Spitalnik, Steven L; Triulzi, Darrell; Devine, Dana V et al. (2015) 2015 proceedings of the National Heart, Lung, and Blood Institute's State of the Science in Transfusion Medicine symposium. Transfusion 55:2282-90
Grozovsky, Renata; Giannini, Silvia; Falet, Hervé et al. (2015) Novel mechanisms of platelet clearance and thrombopoietin regulation. Curr Opin Hematol 22:445-51

Showing the most recent 10 out of 24 publications